News Listing

NewYorkBIO Welcomes Brian Dershowitz as Vice President of Strategic Partnerships & Initiatives

We are excited to announce that we have welcomed our Board of Directors Class of 2025! Together, they will continue to support New York’s bioscience community, our members, and the greater life science community through advocacy and action.

NewYorkBIO addresses concerns over the proposed NIH funding cap, highlighting its potential to disrupt vital biomedical research in New York. The organization is monitoring the situation and remains committed to supporting its members and the state’s life sciences ecosystem.

A recent report from TEConomy highlights New York's growing leadership in the life sciences industry, with bioscience-related R&D expenditures reaching $5.5 billion in FY 2022, significant employment growth, and over $25 billion in venture capital investments over the past five years. Public and private sector initiatives, including policy changes and strategic investments, have positioned New ...

Governor Hochul announces a new State-of-the-Art Cell and Gene Therapy Hub on Long Island, positioning New York as a national leader in innovative medical treatments and fostering economic growth in the life sciences sector.

NewYorkBIO CEO Jennifer Hawks Bland connected with Pharmaceutical Executive for a Q&A focused on life science investor trends, and why New York continues to thrive in the current market, as we continue to witness trends across the industry.

​

FT US PHARMA AND BIOTECH SUMMIT​

May 16, 2024​

In-Person & Digital | Convene at One Liberty Plaza, New York

Composed of accomplished leaders across the life science industry, together they will support innovation.

NewYorkBIO Board Member Annette Bakker's op-ed published in BioSpace discussing nonprofits role in life science innovations.

NewYorkBIO convenes trade leaders from across the country to ring NYSE closing bell and kick off Biotech Month